bioRxivCancer BiologyPreprint
Glucocorticoid receptor activation reorganizes Wnt/LEF1 regulatory circuitry associated with therapeutic response in B-cell acute lymphoblastic leukemia
Robert J. MobleyiD, Damilola OluwalanaiD, Gabriele BaniulyteiD, Minzhang Zheng, Brett Brown, Faten Usrof, Kashi Raj BhattaraiiD, Kelly R. BarnettiD, Virginia A. ValentineiD, Marcus L Valentine, Seth StalleriD, Satoshi Yoshimura, Kristine R. CrewsiD, David T Teachey, Steven Burden, Yong ChengiD, Jun J Yang, Daniel SaviciD
Abstract
Glucocorticoids (GCs) are foundational to B-cell acute lymphoblastic leukemia (B-ALL) therapy, yet how glucocorticoid receptor (GR) activation interacts with lineage regulatory circuitry to shape therapeutic response remains incompletely understood. Using LEF1 to interrogate canonical Wnt regulatory circuitry, we show that GR activation reorganizes GR+LEF1 elements into recruitment, retention, and dissociation states. LEF1 dissociates from Wnt-responsive regulatory elements while being recruited to GRE-rich GR-associated elements that progressively acquire chromatin accessibility, H3K27ac, BRD4 and BRG1. RUNX1 and AP-1 show class-dependent redistribution across LEF1-defined states, extending organization beyond LEF1. GR+LEF1 reorganization is observed in patient-derived B-ALL. GR+LEF1 elements lose accessibility in GC-resistant B-ALL and during diagnosis-to-relapse evolution, with recruitment elements enriched for remodeling. Perturbation of resistance-associated GR+LEF1 elements at BIM and BMF alters GC-induced apoptotic signaling. Together, these findings identify Wnt/LEF1 circuitry as an interface through which therapeutic GR activation reorganizes the B-ALL regulatory landscape into states associated with glucocorticoid response and resistance.
- organism: human
- assay: ChIP-seq
- assay: ATAC-seq
- assay: bulk RNA-seq
- research focus: gene regulatory network inference
- research focus: differential expression
- approach: statistical model
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Mutual antagonism between glucocorticoid and canonical Wnt signaling pathways in B-cell acute lymphoblastic leukemia
B. P. Bergeron, K. R. Barnett, … D. Savic·bioRxiv·Jan 20, 2023
- PI3Kδ inhibition potentiates glucocorticoids in B-ALL by decreased receptor phosphorylation and enhanced gene regulation
J. A. O. Zimmerman, M. Fang, M. A. Pufall·bioRxiv·Feb 10, 2023
- Cell-Intrinsic and Extrinsic Effects of Galectin-1 and Galectin-3 in B-Cell Precursor Acute Lymphoblastic Leukemia
N. Heisterkamp, E. j. Joo, … F. Fei·bioRxiv·Sep 22, 2021
- Remodelling of the glycome of B-cell precursor acute lymphoblastic leukemia cells developing drug-tolerance
Tiago Oliveira, Mingfeng Zhang, … Daniel Kolarich·bioRxiv·Aug 22, 2024
- Glucocorticoids reprogram human AML leukemic stem cells to promote elimination through differentiation and apoptosis
Isabella Angela Iasenza, Yi Ling Sun, … Kolja Eppert·bioRxiv·Sep 15, 2026
- Sequential drug treatment targeting cell cycle and cell fate regulatory programs blocks non-genetic cancer evolution in acute lymphoblastic leukemia
A. Malyukova, M. Lahnalampi, … O. Sangfelt·bioRxiv·Mar 27, 2023